Evidence map›Paper›PMID 29686009›Full record

Trial reportHypertension (Dallas, Tex. : 1979)2018

Influence of Gestational Age at Initiation of Antihypertensive Therapy: Secondary Analysis of CHIPS Trial Data (Control of Hypertension in Pregnancy Study).

Anouk Pels, Ben Willem J Mol, Joel Singer, Terry Lee, Peter von Dadelszen, Wessel Ganzevoort, Elizabeth Asztalos, Laura A Magee, CHIPS Study Group

Open access · hybridAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Hypertension (Dallas, Tex. : 1979), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Toward personalized management of chronic hypertension in pregnancy.American journal of obstetrics and gynecology · 2022
    Review
  6. Article
  7. Article
  8. Article
  9. Hypertensive Disorders of Pregnancy and Medication Use in the 2015 Pelotas (Brazil) Birth Cohort Study.International journal of environmental research and public health · 2020
    Article
  10. Review
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 4 countries.

Anouk PelsFrom the Department of Obstetrics and Gynecology, Academisch Medisch Centrum, Amsterdam, The Netherlands (A.P., W.G.).
Ben Willem J MolDepartment of Medicine, Robinson Institute, School of Pediatrics and Reproductive Health, University of Adelaide, Australia (B.W.J.M.).
Joel SingerSchool of Public and Population Health (J.S., T.L.).
Terry LeeSchool of Public and Population Health (J.S., T.L.).
Peter von DadelszenSchool of Life Course Sciences, King's College London, United Kingdom (P.v.D., L.A.M.).
Wessel GanzevoortFrom the Department of Obstetrics and Gynecology, Academisch Medisch Centrum, Amsterdam, The Netherlands (A.P., W.G.).
Elizabeth AsztalosDepartment of Pediatrics, Obstetrics, and Gynecology, University of Toronto, Canada (E.A.).
Laura A MageeSchool of Life Course Sciences, King's College London, United Kingdom (P.v.D., L.A.M.) laura.a.magee@kcl.ac.uk.
CHIPS Study Group
Sunnybrook Health Science Centre · CAUniversity of British Columbia · CAKing's College London · GBAmsterdam UMC Location University of Amsterdam · NLSouth Australian Health and Medical Research Institute · AU

Funding

CIHR MCT 87522Department of Health 16/167/123
6 · The paper itself

Abstract

For hypertensive women in CHIPS (Control of Hypertension in Pregnancy Study), we assessed whether the maternal benefits of tight control could be achieved, while minimizing any potentially negative effect on fetal growth, by delaying initiation of antihypertensive therapy until later in pregnancy. For the 981 women with nonsevere, chronic or gestational hypertension randomized to less-tight (target diastolic blood pressure, 100 mm Hg), or tight (target, 85 mm Hg) control, we used mixed-effects logistic regression to examine whether the effect of less-tight (versus tight) control on major outcomes was dependent on gestational age at randomization, adjusting for baseline factors as in the primary analysis and including an interaction term between gestational age at randomization and treatment allocation. Gestational age was considered categorically (quartiles) and continuously (linear or quadratic form), and the optimal functional form selected to provide the best fit to the data based on the Akaike information criterion. Randomization before (but not after) 24 weeks to less-tight (versus tight) control was associated with fewer babies with birth weight <10th centile ( CLINICAL

trial registrationURL: https://www.isrctn.com. Unique identifier: ISRCTN71416914.

Indexed as

AdultAntihypertensive AgentsBirth WeightBlood PressureFemaleGestational AgeHumansHypertension, Pregnancy-InducedInfant, NewbornMalePregnancyPregnancy Complications, CardiovascularPregnancy OutcomeAntihypertensive Agentsblood pressurefetal growth restrictionhumanshypertension, pregnancy-inducedpreeclampsiapregnancy outcome

Identifiers

PMID29686009
PMCPMC5959211
OpenAlexW2799774608

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.